STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicin-resistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxifloxacin and clofazimine, known to cause QT prolongation, and severe prolongation was more common on the Short regimen. This study investigated risk factors for QT prolongation with the Short regimen.
Recent Abstracts
E-NNOVATE- Electronic innovations in cancer registration
Pennsylvania Opioid Settlement Funds
Wisconsin Opioid Settlement Funds
North Carolina Opioid Settlement Funds
New Mexico Opioid Settlement Funds
New Jersey Opioid Settlement Funds
Michigan Opioid Settlement Funds
Kentucky Opioid Settlement Funds
Protecting Youth From Online E-Cigarette Marketing: Findings From a New Study in India,…
Using Satellite Data for Air Quality and Health Applications